Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG Dose Comparison for GVHD Prevention in Pediatric HSCT
NCT00934557Phase 3Unknown
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of antithymocyte globulin rabbit in graft-versus-host disease (GVHD), sponsored by IRCCS San Matteo Foundation. Status: unknown.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00934557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00934557.